Toll-like receptor 3 pathway restricts Marek’s disease virus infection

Haitao Zou; Ruixue Su; Jing Ruan; Hongxia Shao; Kun Qian; Jianqiang Ye; Aijian Qin

doi:10.18632/oncotarget.20003

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Toll-like receptor 3 pathway restricts Marek’s disease virus infection

Haitao Zou, Ruixue Su, Jing Ruan, Hongxia Shao, Kun Qian, Jianqiang Ye and Aijian Qin _

PDF | HTML | How to cite

Oncotarget. 2017; 8:70847-70853. https://doi.org/10.18632/oncotarget.20003

Metrics: PDF 1891 views | HTML 2322 views | ?

Abstract

Haitao Zou1,2, Ruixue Su1,2, Jing Ruan1,2, Hongxia Shao1,2,3, Kun Qian1,2,3, Jianqiang Ye1,2,3 and Aijian Qin1,2,3

1Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, P.R. China

2Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu, 225009, P.R. China

3Jiangsu Key Lab of Zoonosis, Yangzhou, Jiangsu, 225009, P.R. China

Correspondence to:

Aijian Qin, email: [email protected]

Keywords: Marek’s disease virus, toll-like receptor 3, poly (I:C), interferon-β, inflammatory cytokines

Abbreviations: IRF3: interferon regulatory factor3, IKKα: IκB kinase α, TANK: TRAF family member-associated NFκB activator

Received: April 04, 2017 Accepted: July 12, 2017 Published: August 07, 2017

ABSTRACT

Marek’s disease virus (MDV) is an α-herpesvirus that causes immune suppression and T lymphoma in chickens. Toll-like receptor 3 (TLR3) is critical for the host immune response against MDV infection. Previously, our team demonstrated that pre-treatment of TLR3 agonist poly (I:C) inhibited Marek’s disease virus infection in chicken embryo fibroblasts (CEFs). However, whether TLR3 inhibits the aggravation of MDV infection is unknown. In the current study, we found that TLR3 activation in MDV-infected CEFs effectively inhibited virus spread. Using pharmacological approaches, we revealed that pro-inflammatory cytokines and interferon-β induced by TLR3 could restrict Marek’s disease virus infection. This study contributes to elucidating the function and mechanism of the TLR3 pathway in host immune responses against MDV infection.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20003

Publication Alerts

Post-Publication Promotion

Research Papers:

Toll-like receptor 3 pathway restricts Marek’s disease virus infection

Abstract